Physician profile
Daniel Kaplan
NPI 1225491632
$8,411.89
in general payments reported to CMS, 2019-2025
46 companies · $1,800 in 2025
The $1,800 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $122 · 2021: $148 · 2022: $4,006 · 2023: $952 · 2024: $1,385 · 2025: $1,800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,873 · Education: $132 · Gift: $59.40 · Long Term Medical Supply Or Device Loan: $49.95 · Entertainment: $21.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,873.42 |
| Education | $132.32 |
| Gift | $59.40 |
| Long Term Medical Supply Or Device Loan | $49.95 |
| Entertainment | $21.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,081.83 | 2022-2025 | Minimed 780g |
| Novo Nordisk INC | $952.27 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $474.30 | 2020-2025 | Tepezza, Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $357.06 | 2021-2025 | Breztri, Tagrisso, Calquence |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.18 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $309.33 | 2022-2025 | |
| Radius Health, INC. | $304.46 | 2023-2025 | Tymlos |
| Mannkind Corporation | $250.37 | 2022-2025 | Afrezza |
| Merck Sharp & Dohme LLC | $196.43 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Abbott Laboratories | $195.62 | 2022-2025 | Freestyle Insulinx, Freestyle Libre 3 |
| Lilly USA, LLC | $167.58 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Dexcom, INC. | $165.17 | 2022-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $148.86 | 2021-2025 | |
| Janssen Biotech, INC. | $140.87 | 2025 | Carvykti, Rybrevant, Tecvayli |
| Pfizer INC. | $114.23 | 2022-2024 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101.83 | 2024-2025 | |
| Springworks Therapeutics, INC. | $78.12 | 2025 | Ogsiveo |
| Xeris Pharmaceuticals, INC. | $76.26 | 2024-2025 | Recorlev |
| Astellas Pharma US INC | $73.50 | 2025 | Veozah |
| Madrigal Pharmaceuticals | $63.03 | 2025 | Rezdiffra |
| Pharmacyclics LLC, An Abbvie Company | $60.02 | 2022-2023 | Imbruvica |
| Novartis Pharmaceuticals Corporation | $58.86 | 2025 | |
| Kyowa Kirin, INC. | $56.12 | 2024 | Crysvita |
| Ascendis Pharma Endocrinology INC | $49.96 | 2025 | Yorvipath |
| Ascensia Diabetes Care US INC. | $48.89 | 2024 | |
| Glaxosmithkline, LLC. | $47.12 | 2023 | Shingrix, Arexvy |
| Tandem Diabetes Care, INC. | $40.78 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Cequr Corporation | $33.84 | 2023-2025 | Cequr Simplicity |
| Integra Lifesciences Corporation | $30.85 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Alexion Pharmaceuticals, INC. | $30.44 | 2023 | Strensiq |
| Coherus Oncology, INC. | $29.13 | 2025 | Loqtorzi |
| Takeda Pharmaceuticals U.S.A., INC. | $27.19 | 2023 | |
| Genmab U.S., INC. | $26.44 | 2025 | Epkinly |
| Insulet Corporation | $25.45 | 2025 | Omnipod |
| Edwards Lifesciences Corporation | $24.87 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Aurinia Pharma U.S., INC. | $24.02 | 2022 | |
| Pharmacosmos Therapeutics INC. | $23.91 | 2024 | Monoferric |
| Tempus Ai, INC | $23.66 | 2025 | Xt Cdx |
| Davol INC. | $22.60 | 2024 | Phasix Mesh |
| Regeneron Healthcare Solutions, INC. | $21.58 | 2024 | Libtayo |
| Optos, INC. | $21.38 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Progenics Pharmaceuticals, INC. | $21.03 | 2024 | |
| Amphastar Pharmaceuticals, INC. | $20.23 | 2025 | |
| Sequel Med Tech, LLC | $19.48 | 2025 | Twiist |
| Stryker Corporation | $16.51 | 2025 | Molli |
| Collegium Pharmaceutical, INC. | $14.23 | 2023 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.